Intuitive Surgical Total Cost of Revenue decreased by 2.2% to $940.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.2%, from $795.70M to $940.30M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 18.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $440.30M | $431.90M | $489.90M | $478.00M | $498.80M | $505.30M | $544.10M | $583.20M | $584.00M | $576.50M | $650.90M | $645.20M | $637.20M | $664.20M | $771.30M | $795.70M | $822.10M | $842.70M | $961.90M | $940.30M |
| QoQ Change | — | -1.9% | +13.4% | -2.4% | +4.4% | +1.3% | +7.7% | +7.2% | +0.1% | -1.3% | +12.9% | -0.9% | -1.2% | +4.2% | +16.1% | +3.2% | +3.3% | +2.5% | +14.1% | -2.2% |
| YoY Change | — | — | — | — | +13.3% | +17.0% | +11.1% | +22.0% | +17.1% | +14.1% | +19.6% | +10.6% | +9.1% | +15.2% | +18.5% | +23.3% | +29.0% | +26.9% | +24.7% | +18.2% |